CS logo
small CS logo
Sutter East Bay Medical Foundation

Berkeley, California, United States
Medical clinic in Berkeley, California
2500 Milvia St, Berkeley, CA 94704

About Sutter East Bay Medical Foundation


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Genzyme, a Sanofi Company
2
Hoffmann-La Roche
2
TherapeuticsMD
2
H. Lundbeck A/S
1
PDL BioPharma, Inc.
1
Sunovion
1
Total Rows: 6

Clinical Trials at Sutter East Bay Medical Foundation


During the past decade, Sutter East Bay Medical Foundation conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11000000110033111100Started TrialsCompleted Trails2016201720182019202001234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis
2005-04-01
2006-10-01
Completed
270
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
2007-10-01
2011-09-01
Completed
840
Eslicarbazepine Acetate Monotherapy Long Term Study
2009-08-01
2017-04-15
Completed
274
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
2009-08-01
2016-02-01
Completed
1,314
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
2011-03-02
2022-12-31
Completed
735
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
2013-08-05
2016-10-28
Completed
1,845
Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
2014-09-01
2015-10-01
Completed
764
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
2016-02-11
2022-09-09
Completed
254

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Sutter East Bay Medical Foundation" #1 sponsor was "Genzyme, a Sanofi Company" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "TherapeuticsMD" with 2 trials sponsored, "H. Lundbeck A/S" with 1 trials sponsored and "PDL BioPharma, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sutter East Bay Medical Foundation" #1 collaborator was "Bayer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGenzyme, a Sanofi Company: 2Genzyme, a Sanofi Company: 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2TherapeuticsMD: 2TherapeuticsMD: 2H. Lundbeck A/S: 1H. Lundbeck A/S: 1PDL BioPharma, Inc.: 1PDL BioPharma, Inc.: 1Sunovion: 1Sunovion: 1

Created with Highcharts 11.1.0Top CollaboratorsBayer: 2Bayer: 2

Clinical Trials Conditions at Sutter East Bay Medical Foundation


According to Clinical.Site data, the most researched conditions in "Sutter East Bay Medical Foundation" are "Menopause" (2 trials), "Multiple Sclerosis, Primary Progressive" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Dyspareunia" (1 trials) and "Epilepsy" (1 trials). Many other conditions were trialed in "Sutter East Bay Medical Foundation" in a lesser frequency.

Clinical Trials Intervention Types at Sutter East Bay Medical Foundation


Most popular intervention types in "Sutter East Bay Medical Foundation" are "Drug" (7 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Estradiol" (2 trials), "Ocrelizumab" (2 trials), "Alemtuzumab 12 mg" (1 trials) and "Alemtuzumab 24 mg" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Sutter East Bay Medical Foundation


The vast majority of trials in "Sutter East Bay Medical Foundation" are 7 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Sutter East Bay Medical Foundation


Currently, there are NaN active trials in "Sutter East Bay Medical Foundation". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Sutter East Bay Medical Foundation, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sutter East Bay Medical Foundation, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 7Phase 3: 7Phase 2: 1Phase 2: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 8Completed: 8Recruiting: 1Recruiting: 1